Johnson & Johnson vs. Royalty Pharma plc Class A Ordinary Shares
JNJ
Johnson & Johnson
$260.35 -0.66%
VS RPRXRoyalty Pharma plc Class A Ordinary Shares
$58.60 +0.07%
Johnson & Johnson (JNJ) comes out ahead, leading on 7 of 11 compared factors.
Size & Scale
| JNJ | RPRX | |
|---|---|---|
| Market Cap | $628.65 billion | $26.37 billion |
| Revenue (TTM) | $97.93 billion | $2.54 billion |
| Net Income (TTM) | $21.04 billion | $1.35 billion |
JNJ leads on 3 of 3 size & scale factors.
Valuation
| JNJ | RPRX | |
|---|---|---|
| P/E Ratio | 30.20 | 31.17 |
| Price / Book | 7.40 | 2.69 |
| Price / Sales | 6.42 | 10.40 |
JNJ leads on 2 of 3 valuation factors.
Profitability
| JNJ | RPRX | |
|---|---|---|
| Net Margin | 21.48% | 53.23% |
| Return on Equity | 24.76% | 13.79% |
JNJ and RPRX split the profitability factors evenly.
Dividend
| JNJ | RPRX | |
|---|---|---|
| Dividend Yield | 2.06% | 1.60% |
| Payout Ratio | 62.18 | 50.00 |
JNJ and RPRX split the dividend factors evenly.
Risk & Sentiment
| JNJ | RPRX | |
|---|---|---|
| Short Interest | 0.67% | 0.34% |
RPRX leads on 1 of 1 risk & sentiment factors.
Dig deeper: JNJ overview, JNJ financials, RPRX overview, RPRX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.